The objective of the present study is to evaluate the cytotoxic activity of Cuminum cyminum Linn ethanolic extract using in-vitro study. Following seven human cancer cell lines Colon 502713, Colo-205, Hep-2, A-549, OVCAR-5, PC-5, SF-295 were taken. The anti-cancer properties of cumin seed was determined using SRB assay. Activity was found to be 25%, 61%, 40%, 31%, 31%, 28%, 27% against SF-295, Colon 502713, Colo-205, Hep-2, A-549, OVCAR-5, PC-5 human cancer cell lines respectively. Cuminum cyminum Linn extract showed 61% maximum activity against Colon 502713 cell line. only 15 species (belonging to ten genera and nine families) have been utilized in cancer chemotherapy at a clinical level, whereas the rest of the identified species are either active against cancer cell lines or exhibit chemotherapeutic properties on tumor-bearing animals under experimental conditions. The outlook of phytochemistry based cancer therapy is discussed, particularly in the perspective of identifying immunomodulatory anti-cancer agents with minimal toxicity on healthy tissues Cuminum cyminum Linn. belongs to the family Umbelliferae. The common English name is Cumin. It is native of Mediterranean region. In India, it is cultivated mainly in the Punjab and Uttar Pradesh. The plant is a short annual herb with small pinkish flowers. The elongated oval fruit are aromatic and light brown in colour. The fruit is a good source of thymol; it is stomachic, diuretic, carminative, stimulant and astringent. It is prescribed in dyspepsia, diarrhea and hoarseness of voice. It is given for promoting secretion of milk. We studied this plant for possible anti-cancer activity using SRB assay against seven human cancer cell lines.